BSELink Pharma Chem LtdHighNegative
Announced Thu, 13 Nov · 12:41 IST

Outcome of Board Meeting held on Thursday, 13th November, 2025.

Kmp ResignedManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The board approved the unaudited financial results for the quarter and half year ended September 30, 2025. Revenue from operations for Q2 FY26 stood at Rs 629.32 lakhs, down from Rs 781.48 lakhs in the previous quarter, while H1 FY26 revenue rose to Rs 1,410.80 lakhs versus Rs 1,364.45 lakhs in H1 FY25. The company swung back to profit, posting a profit before tax of Rs 52.19 lakhs for H1 FY26 compared to a loss of Rs 2.88 lakhs a year ago, with EPS of Rs 0.94. The board also accepted the resignation of Company Secretary and Compliance Officer Ms. Khushbu Prakashbhai Patel, effective December 16, 2025, citing better prospects outside the organisation. Auditor CNK & Associates LLP issued an unmodified limited review report on the results.

Likely market impact

Returning to profitability in H1 FY26 is a positive for shareholders, though the sequential dip in Q2 revenue and thin margins suggest the recovery is modest. The Company Secretary exit is a routine KMP change and unlikely to materially affect the stock, though investors may watch for a timely replacement to avoid any compliance gaps.